It is now approved as afamelanotide in both the United States and Europe to prevent sun-related skin damage in patients with erythropoietic protoporphyria
A long-acting glucose dependent insulinotropic polypeptide receptor agonist shows weight loss without nausea or vomiting, in: American Diabetes Association 83rd Annual Scientific Sessions, San Diego, CA, USA, 23 26 June 2023
Based on what the platform advertises, VivioMD may be relevant to people interested in telehealth-based GLP-1 access without insurance, who prefer a remote assessment over an in-person clinic visit, who are open to weighing compounded options against FDA-approved brand-name pathways, and who want ongoing provider messaging between visits
The anabolic response to protein ingestion during recovery from exercise has no upper limit in magnitude and duration in vivo in humans
Drug interactions require attention
Regular follow-up enables timely identification of adverse effects, adjustment of thyroid hormone replacement as needed, and assessment of therapeutic response to ensure safe, effective care
